163 related articles for article (PubMed ID: 37870643)
1. Heterogenous electrophysiological features in early stage of hereditary transthyretin amyloidosis neuropathy.
Tozza S; Palumbo G; Severi D; Iovino A; Spina E; Aruta F; Cassano E; Iodice R; Dubbioso R; Ruggiero L; Nolano M; Santoro L; Manganelli F
Neurol Sci; 2024 Apr; 45(4):1685-1689. PubMed ID: 37870643
[TBL] [Abstract][Full Text] [Related]
2. The neuropathy in hereditary transthyretin amyloidosis: A narrative review.
Tozza S; Severi D; Spina E; Iovino A; Aruta F; Ruggiero L; Dubbioso R; Iodice R; Nolano M; Manganelli F
J Peripher Nerv Syst; 2021 Jun; 26(2):155-159. PubMed ID: 33960565
[TBL] [Abstract][Full Text] [Related]
3. Red flags and adjusted suspicion index for distinguishing hereditary transthyretin amyloid polyneuropathy from idiopathic axonal polyneuropathy.
Warendorf JK; van der Star GM; Dooijes D; Notermans NC; Vrancken AFJE
Neurol Sci; 2023 Oct; 44(10):3679-3685. PubMed ID: 37266816
[TBL] [Abstract][Full Text] [Related]
4. Same same, but different? The neurological presentation of wildtype transthyretin (ATTRwt) amyloidosis.
Kleefeld F; Scherret E; Knebel F; Messroghli D; Heidecker B; Wetz C; Schatka I; Barzen G; Tschöpe C; Amthauer H; Hahn K
Amyloid; 2022 Jun; 29(2):92-101. PubMed ID: 34994254
[TBL] [Abstract][Full Text] [Related]
5. A compound score to screen patients with hereditary transthyretin amyloidosis.
Tozza S; Severi D; Spina E; Di Paolantonio A; Iovino A; Guglielmino V; Aruta F; Nolano M; Sabatelli M; Santoro L; Luigetti M; Manganelli F
J Neurol; 2022 Aug; 269(8):4281-4287. PubMed ID: 35279758
[TBL] [Abstract][Full Text] [Related]
6. Drug and Gene Therapy for Treating Variant Transthyretin Amyloidosis (ATTRv) Neuropathy.
Dardiotis E; Kyriakides T
Curr Neuropharmacol; 2023; 21(3):471-481. PubMed ID: 36366846
[TBL] [Abstract][Full Text] [Related]
7. Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis.
Carroll A; Dyck PJ; de Carvalho M; Kennerson M; Reilly MM; Kiernan MC; Vucic S
J Neurol Neurosurg Psychiatry; 2022 Jun; 93(6):668-678. PubMed ID: 35256455
[TBL] [Abstract][Full Text] [Related]
8. Correlation between a commercial electrophysiological test of sudomotor function and intraepidermal nerve fiber density in hereditary transthyretin amyloidosis.
Masuda T; Misumi Y; Nomura T; Yamakawa S; Tasaki M; Obayashi K; Ando Y; Ueda M
Muscle Nerve; 2024 Jan; 69(1):99-102. PubMed ID: 37960924
[TBL] [Abstract][Full Text] [Related]
9. Detailed clinical, physiological and pathological phenotyping can impact access to disease-modifying treatments in ATTR carriers.
Beauvais D; Labeyrie C; Cauquil C; Francou B; Eliahou L; Not A; Echaniz-Laguna A; Adam C; Slama MS; Benmalek A; Leonardi L; Rouzet F; Adams D; Algalarrondo V; Beaudonnet G
J Neurol Neurosurg Psychiatry; 2024 May; 95(6):489-499. PubMed ID: 37875336
[TBL] [Abstract][Full Text] [Related]
10. Transthyretin Variant Amyloidosis with a TTR A97D (p.A117D) Mutation Manifesting Remarkable Asymmetric Neuropathy.
Ikeda K; Yamamoto D; Usui K; Takeuchi H; Oka N; Katoh N; Yazaki M; Kametani F; Nishino I; Hisahara S
Intern Med; 2023 Aug; 62(15):2261-2266. PubMed ID: 36543209
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiological demyelinating features in hereditary ATTR amyloidosis.
Ohashi N; Kodaira M; Morita H; Sekijima Y
Amyloid; 2019 Mar; 26(1):15-23. PubMed ID: 30688105
[TBL] [Abstract][Full Text] [Related]
12. Hereditary transthyretin amyloidosis in middle-aged and elderly patients with idiopathic polyneuropathy: a nationwide prospective study.
Fargeot G; Echaniz-Laguna A; Labeyrie C; Svahn J; Camdessanché JP; Cintas P; Chanson JB; Esselin F; Piedvache C; Verstuyft C; Genestet S; Lagrange E; Magy L; Péréon Y; Sacconi S; Signate A; Nadaj-Pakleza A; Taithe F; Viala K; Tard C; Poinsignon V; Cauquil C; Attarian S; Adams D
Amyloid; 2024 Mar; 31(1):62-69. PubMed ID: 37855400
[TBL] [Abstract][Full Text] [Related]
13. Skin amyloid deposits and nerve fiber loss as markers of neuropathy onset and progression in hereditary transthyretin amyloidosis.
Leonardi L; Adam C; Beaudonnet G; Beauvais D; Cauquil C; Not A; Morassi O; Benmalek A; Trassard O; Echaniz-Laguna A; Adams D; Labeyrie C
Eur J Neurol; 2022 May; 29(5):1477-1487. PubMed ID: 35100482
[TBL] [Abstract][Full Text] [Related]
14. An Exploratory Study of Cognitive Involvement in Hereditary Transthyretin Amyloidosis.
Durmuş H; Çakar A; Demirci H; Alaylioglu M; Gezen-Ak D; Dursun E; Gülşen Parman Y
Acta Neurol Scand; 2021 Dec; 144(6):640-646. PubMed ID: 34322872
[TBL] [Abstract][Full Text] [Related]
15. Clinical and apparative investigation of large and small nerve fiber impairment in mixed cohort of ATTR-amyloidosis: impact on patient management and new insights in wild-type.
Papagianni A; Ihne S; Zeller D; Morbach C; Üçeyler N; Sommer C
Amyloid; 2022 Mar; 29(1):14-22. PubMed ID: 34632904
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of assessing progression of transthyretin amyloid polyneuropathy using nerve conduction studies: Findings from the Transthyretin Amyloidosis Outcomes Survey (THAOS).
Waddington-Cruz M; Ando Y; Amass L; Kiszko J; Chapman D; Sekijima Y;
J Peripher Nerv Syst; 2021 Jun; 26(2):160-166. PubMed ID: 33844361
[TBL] [Abstract][Full Text] [Related]
17. Deterioration after Liver Transplantation and Transthyretin Stabilizer Administration in a Patient with ATTRv Amyloidosis with a Leu58Arg (p.Leu78Arg) TTR Variant.
Hikishima S; Sakai K; Akagi A; Yamaguchi H; Shibata S; Hayashi K; Nakano H; Kanemoto M; Usui Y; Taniguchi Y; Komatsu J; Nakamura-Shindo K; Nozaki I; Hamaguchi T; Ono K; Iwasa K; Yamada M
Intern Med; 2022 Aug; 61(15):2347-2351. PubMed ID: 35283385
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of Patients with Hereditary Transthyretin Amyloidosis-Polyneuropathy (ATTRv-PN) in NEURO-TTRansform, an Open-label Phase 3 Study of Eplontersen.
Coelho T; Waddington Cruz M; Chao CC; Parman Y; Wixner J; Weiler M; Barroso FA; Dasgupta NR; Jung SW; Schneider E; Viney NJ; Dyck PJB; Ando Y; Gillmore JD; Khella S; Gertz MA; Obici L; Berk JL
Neurol Ther; 2023 Feb; 12(1):267-287. PubMed ID: 36525140
[TBL] [Abstract][Full Text] [Related]
19. Sex-Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis: Insights From THAOS.
Caponetti AG; Rapezzi C; Gagliardi C; Milandri A; Dispenzieri A; Kristen AV; Wixner J; Maurer MS; Garcia-Pavia P; Tournev I; Planté-Bordeneuve V; Chapman D; Amass L;
JACC Heart Fail; 2021 Oct; 9(10):736-746. PubMed ID: 34391735
[TBL] [Abstract][Full Text] [Related]
20. Corneal confocal microscopy identifies corneal nerve loss and increased Langerhans cells in presymptomatic carriers and patients with hereditary transthyretin amyloidosis.
Thimm A; Carpinteiro A; Oubari S; Papathanasiou M; Kessler L; Rischpler C; Malik RA; Herrmann K; Reinhardt HC; Rassaf T; Kleinschnitz C; Hagenacker T; Stettner M
J Neurol; 2023 Jul; 270(7):3483-3491. PubMed ID: 37014422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
